Characterization of a novel cullin5 binding domain in HIV-1 vif

被引:51
作者
Xiao, Zuoxiang
Xiong, Yong
Zhang, Wenyan
Tan, Lindi
Ehrlich, Elana
Guo, Deyin
Yu, Xiao-Fang [1 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA
[2] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China
基金
美国国家卫生研究院;
关键词
cullin; zinc; ubiquitin ligase; HIV; Vif;
D O I
10.1016/j.jmb.2007.07.029
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human immunodeficiency virus tyoe 1 (HIV-1) Vif counteracts host restriction cytidine deaminase (APOBEC3G) A3G by co-opting the cellular ubiquitin-proteasome machinery. Vif utilizes a viral-specific BC-box to recruit ElonginB-ElonginC and a novel zinc-binding HCCH motif to recruit Cullin5 (Cul5) to form an E3 ubiquitin ligase targeting A3G for polyubiquitination and subsequently proteasomal degradation. To determine the structural requirements in HIV-1 Vif HCCH motif for Cu15 binding and Vif function, we investigated the arrangement of the His and Cys residues, the role of the spacing between them, and the requirement for the conserved residues. Our data demonstrate that exchanging Cys for His and vice versa in the highly conserved Zn-coordinating HCCH motif disrupted Vif function and interaction with Cu15. Moreover, the maintenance of both conserved residues and spacing within the HCCH motif is critical for Vif function. We have identified a "viral Cu15 box" with consensus Hx2YFxCFx4 Phi x2A Phi x7-8Cx5H that is required for Cu15 selection and subsequent A3G degradation. This novel motif may represent a potential new target for anti-viral drug development. (c) 2007 Published by Elsevier Ltd.
引用
收藏
页码:541 / 550
页数:10
相关论文
共 61 条
[1]   Antiviral potency of APOBEC proteins does not correlate with cytidine deamination [J].
Bishop, Kate N. ;
Holmes, Rebecca K. ;
Malim, Michael H. .
JOURNAL OF VIROLOGY, 2006, 80 (17) :8450-8458
[2]   Cytidine deamination of retroviral DNA by diverse APOBEC proteins [J].
Bishop, KN ;
Holmes, RK ;
Sheehy, AM ;
Davidson, NO ;
Cho, SJ ;
Malim, MH .
CURRENT BIOLOGY, 2004, 14 (15) :1392-1396
[3]   APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells [J].
Bogerd, HP ;
Wiegand, HL ;
Doehle, BP ;
Lueders, KK ;
Cullen, BR .
NUCLEIC ACIDS RESEARCH, 2006, 34 (01) :89-95
[4]   Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection [J].
Chackerian, B ;
Long, EM ;
Luciw, PA ;
Overbaugh, J .
JOURNAL OF VIROLOGY, 1997, 71 (05) :3932-3939
[5]   APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons [J].
Chen, H ;
Lilley, CE ;
Yu, Q ;
Lee, DV ;
Chou, J ;
Narvaiza, I ;
Landau, NR ;
Weitzman, MD .
CURRENT BIOLOGY, 2006, 16 (05) :480-485
[6]   High-molecular-mass APOBEC3G complexes restrict alu retrotransposition [J].
Chiu, Ya-Lin ;
Witkowska, H. Ewa ;
Hall, Steven C. ;
Santiago, Mario ;
Soros, Vanessa B. ;
Esnault, Cecile ;
Heidmann, Thierry ;
Greene, Warner C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (42) :15588-15593
[7]   H-1-NMR STRUCTURE AND BIOLOGICAL STUDIES OF THE HIS(23)-]CYS MUTANT NUCLEOCAPSID PROTEIN OF HIV-1 INDICATE THAT THE CONFORMATION OF THE FIRST ZINC-FINGER IS CRITICAL FOR VIRUS INFECTIVITY [J].
DEMENE, H ;
DONG, CZ ;
OTTMANN, M ;
ROUYEZ, MC ;
JULLIAN, N ;
MORELLET, N ;
MELY, Y ;
DARLIX, JL ;
FOURNIEZALUSKI, MC ;
SARAGOSTI, S ;
ROQUES, BP .
BIOCHEMISTRY, 1994, 33 (39) :11707-11716
[8]   Highly purified human immunodeficiency virus type 1 reveals a virtual absence of vif in virions [J].
Dettenhofer, M ;
Yu, XF .
JOURNAL OF VIROLOGY, 1999, 73 (02) :1460-1467
[9]   Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif [J].
Doehle, BP ;
Schäfer, A ;
Cullen, BR .
VIROLOGY, 2005, 339 (02) :281-288
[10]   Dual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retroviruses [J].
Esnault, C ;
Millet, J ;
Schwartz, O ;
Heidmann, T .
NUCLEIC ACIDS RESEARCH, 2006, 34 (05) :1522-1531